COMMUNIQUÉS West-GlobeNewswire

Enzymatica AB: New ColdZyme study in elite athletes confirms preventive effect and reduced duration of illness
09/04/2018
News Lund April 9, 2018 New ColdZyme study in elite athletes confirms preventive effect and reduced duration of illness Enzymatica is now publishing the results of a second study 1 in which elite athletes used ColdZyme [...]
Transactions under Novozymes’ stock buyback program
09/04/2018
Please read the full announcement in the attached PDF Attachment 2018_12_Stock_Buybackprogram_EN
MPI - Oncology Venture exercises option to inlicense Dovitinib a Phase 3 Multi Tyrosine Kinase Inhibitor
09/04/2018
Hoersholm, Denmark, April 9, 2018 - Medical Prognosis Institute A/S (MPI:ST) ("MPI" or the "Company") today announced that Oncology Venture has entered into an agreement with Novartis Pharma AG (Basel, Switzerland) for [...]
Solon Eiendom ASA : Strategic equity investment by Union - and subsequent offering
09/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
Solon Eiendom ASA : KEY INFORMATION RELATING TO THE SUBSEQUENT OFFERING
09/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
RECORDATI ACQUIRES INTERNATIONAL RIGHTS TO CYSTAGON® FROM MYLAN
09/04/2018
Milan, 9 April 2018 - Recordati announces the completion of an agreement with Mylan for the acquisition of the rights to Cystagon® (cysteamine bitartrate), indicated for the treatment of proven nephropathic cystinosis [...]
Shire plc : Rule 2.9 Announcement
09/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 9 April 2018 Shire [...]
Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Canada by Avir Pharma
09/04/2018
Basel, Switzerland, April 09, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that its partner Avir Pharma Inc. ("Avir Pharma") has launched Basilea's hospital antibiotic Zevtera ® (ceftobiprole) in Canada [...]
INNATE PHARMA : Upcoming investor conferences
09/04/2018
upcoming investor conferences Marseille, France, April 9, 2018, 7:00 AM CEST Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today announces that it will be present at the following investor events [...]
INNATE PHARMA : Prochains rendez-vous investisseurs
09/04/2018
PROCHAINS RENDEZ-VOUS INVESTISSEURS Marseille, le 9 avril 2018, 7h00 CEST Innate Pharma SA (Euronext Paris : FR0010331421 - IPH) annonce aujourd'hui qu'elle sera présente aux événements investisseurs suivants : H.C. [...]
argenx appoints Keith Woods as Chief Operating Officer
09/04/2018
April 9, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]
Novartis enters agreement to acquire AveXis Inc. for USD 8.7 bn to transform care in SMA and expand position as a gene therapy and Neuroscience leader
09/04/2018
AveXis lead product candidate, AVXS-101, has potential to be first-ever one-time gene replacement therapy for spinal muscular atrophy (SMA), a disease which results in early death or lifelong disability with [...]
AveXis Enters Agreement to be Acquired by Novartis AG for $8.7 billion
09/04/2018
Novartis to acquire AveXis for $218 per share in cash AveXis’ lead product candidate, AVXS-101, expected to enhance Novartis’s position as a gene therapy and neuroscience leader Transaction expected to be completed in [...]
Menlo Therapeutics Announces Results from a Phase 2 Trial of Serlopitant for Pruritus Associated with Atopic Dermatitis
09/04/2018
Company to Host Conference Call Monday, April 9 at 4:00am PT / 7:00am ET REDWOOD CITY, Calif., April 08, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO ), a late-stage biopharmaceutical company focused [...]
Arcturus Therapeutics Issues Statement Regarding Timing of Extraordinary General Meeting of Shareholders
08/04/2018
Postponement due to Joseph Payne’s Focus on Advancing His Personal Agenda at the Expense of Arcturus Shareholders SAN DIEGO, April 08, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA [...]
Tower One Wireless Comments on Marketing Activities
07/04/2018
VANCOUVER, British Columbia, April 06, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (Pink Sheets:TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) , announced today that it has been requested by the [...]
Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
06/04/2018
BURLINGTON, Mass., April 06, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced a grant of inducement stock options to four new employees for an aggregate of 12,300 shares of common [...]
Inspire Medical Systems, Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering
06/04/2018
MINNEAPOLIS, April 06, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for [...]
HealthEquity Appoints Angelique Hill as EVP of Operations
06/04/2018
DRAPER, Utah, April 06, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ) (“HealthEquity” or the “Company”), the nation’s largest health savings account (HSA) non-bank custodian, today announced that it has [...]

Pages